News
Ramona resident seeks speedy FDA approval for COVID-19 stem cell treatment
As CEO of Personalized Stem Cells, Inc. in Poway, Dr. Harman is involved in the company’s quest to have the Food & Drug Administration (FDA) fast-track its Investigational New Drug application for the treatment of COVID-19 patients with stem cells.
COVID-19 Stem Cell Treatments – Urgent Charitable Donations Call
Donations needed to ramp up stem cell production to provide treatments for COVID-19 patients.
CoronaStem 1 Trial – Personalized Stem Cells Files for Expedited FDA Approval to Treat COVID-19 Patients
Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...
COVID-19 Emergency Stem Cell Treatment Collaboration in San Diego
Personalized Stem Cells, Inc. and Calidi Biotherapeutics collaborate to rapidly bring a stem cell therapy into clinical trials for COVID-19 patients.
Personalized Stem Cells Chief Scientific Officer, Dr. Robert Harman, Recently Presented at Trauma Conference
Personalized Stem Cells, Inc. recently attended and presented at the Cellular Therapies and Transfusion Medicine in Trauma and Critical Care conference.
Personalized Stem Cells, Inc. Sponsors Arthritis Foundation Event in Los Angeles
Personalized Stem Cells, Inc. was a primary sponsor of an event put on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center in Los Angeles, California.
Personalized Stem Cells, Inc. Announces First Patients Treated in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
Personalized Stem Cells, Inc. announces first patients treated in FDA approved clinical trial for treatment of knee osteoarthritis with stem cells.
Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
Personalized Stem Cells, Inc. announces first patients enrolled in FDA approved clinical trial for treatment of knee osteoarthritis with stem cells.
Personalized Stem Cells, Inc. Announces Clinical Trial Sites Qualifed for FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
Personalized Stem Cells, Inc. announces clinical trial sites qualified for FDA approved clinical trial for treatment of osteoarthritis with stem cells.
Personalized Stem Cells, Inc. Announces FDA Approval of IND Application for Treatment of Osteoarthritis with Stem Cells
Personalized Stem Cells, Inc. Announces FDA Approval of IND Application for Treatment of Osteoarthritis with Stem Cells.